Skip to main content
Log in

Dopamine transporter immunoreactivity in peripheral blood lymphocytes in Parkinson's disease

  • Short Communication
  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Summary.

There is increasing interest in the identification of biological markers for the early diagnosis of Parkinson's disease (PD). Previous studies indicate changes of dopamine content, tyrosine hydroxylase immunoreactivity and dopamine receptors in peripheral blood lymphocytes (PBL) in PD. Here we demonstrate a reduction of dopamine transporter immunoreactivity in PBL in the early clinical stages of the disease. These findings contribute to our understanding of the peripheral dopamine system in PD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received November 16, 2000; accepted March 19, 2001

Rights and permissions

Reprints and permissions

About this article

Cite this article

Caronti, B., Antonini, G., Calderaro, C. et al. Dopamine transporter immunoreactivity in peripheral blood lymphocytes in Parkinson's disease. J Neural Transm 108, 803–807 (2001). https://doi.org/10.1007/s007020170030

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s007020170030

Navigation